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Abstract 
Expenditure on medical treatment has tended to increase as a proportion of national income 
throughout the European Union. Overall there has been a rising trend in the mean as low-
spending countries such as the UK have faced political pressure to spend at least the average EU 
proportion of their national income on the provision of health services, medical treatment and 
long-term care. A particular concern is that with an ageing population and therefore the prospect 
of more old people around, the pressures on health care expenditure will increase further. 
The aim of this 6
th work package (WP6) of the AHEAD project is to explain how demand and 
supply factors influence aggregate health care expenditure with a specific focus on age 
composition. Several studies in the past have shown that health care expenditure is not only 
influenced by demand factors, but also by those on the supply side, particularly technological 
progress, political decisions and economic framework conditions.  
In contrast with other studies (and aside from the focus on age), WP6 emphasises variables 
describing health care and financing systems. The idea is that the inclusion of these variables 
affords a better explanation of health care expenditure. This report collects data on demand, 
supply and utilisation of health care from official statistics and creates additional variables 
describing the health care and financing systems based on a literature review. In total, 63 
variables are included in a basic data set for 28 countries, mostly covering the period 1980-
2003. A brief statistical overview shows the development of some of the variables in the 
countries covered. The expected strong connection between health care expenditure and GDP 
can be seen in a cross-section analysis for 2003. The relation between health care expenditure 
and the share of the elderly in the population was also positive, but not as strong as in the case 
of GDP. 
 
 
 
 
 
* Erika Schulz is with DIW, Berlin.  
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Introduction 
Expenditure on medical treatment has tended to increase as a proportion of national income 
throughout the European Union. There has been a rising trend in the mean as low-spending 
countries such as the UK have faced political pressure to spend at least the average EU 
proportion of their national income on the provision of health services, medical treatment and 
long-term care. A particular worry is that with an ageing population and therefore the prospect 
of more old people around, the pressures on health care expenditure will increase further. This 
issue is of concern in its own right and because of its fiscal implications. Rising health 
expenditures in turn put pressure on the targets of the Stability and Growth Pact. They also 
prompt the question of whether budgetary targets should be tightened ahead of projected growth 
in public expenditures, so as to ‘save up’ for future spending and to keep expected future tax 
rates reasonably constant. 
The main focus of the public discussion is the impact of an ageing society on health and long-
term care expenditure. Cross-sectional data show a strong positive correlation between age and 
health expenditure (EPC, 2001). In all EU countries the picture is nearly the same: a strong 
increase with age. Therefore, it is expected that the ageing process could affect the sustainability 
of health care systems. But health expenditure is not only influenced by demand. In addition to 
demography, other important factors influence health expenditures, especially medical and 
technological progress, political decisions and economic framework conditions. A study for 
Germany showed that health expenditures were mostly influenced by technological progress 
and not by the ageing process (Breyer, 1999). The same results were observed for health care 
expenditures in the US (Okunade & Murthy, 2002). 
Generally, the level of health expenditure is the result of demand and supply factors, political 
decisions (as well as those by health-care insurance schemes) and overall economic conditions 
(see Figure 1). Ageing could be an important factor on the demand side, but other factors may 
be more relevant for the development of health expenditure. Particularly in the new member 
states, changes in health care systems have an important influence on principally the supply side 
and therefore the development of health care expenditure. Thus the AHEAD project focuses on 
both demand and supply factors. Of specific interest is the study of the extent to which both 
factors respectively affect aggregate health expenditure, taking age composition into account. 
This study builds on the Ageing Health and Retirement (AGIR) project (Ref. No. QLK6-CT-
2001-00517), which estimated the expected effect on health care expenditures of an ageing 
population as seen predominantly from the demand side. It adds to the AGIR study by including 
a composite of both demand- and supply-side factors influencing the aggregate expenditures. 
Hence, rather than making simple forecasts from demographic variables, it aims at making 
predictions of changes in aggregate expenditure owing to marginal changes in age composition 
by taking supply-side factors into account. The predictions are to be based on empirical 
evidence from the past (since 1980). 2 | ERIKA SCHULZ  
 
Figure 1. Determinants of health care expenditure 
 
Several earlier studies have shown a positive association between aggregate income per capita 
and health care expenditures per capita. Newhouse (1977) based his study on data from 13 
developed countries and his main findings revealed that 92% of the variation in medical 
expenditure per capita could be explained by the variation in national income per person. Later 
studies (Gerdtham et al., 1992) confirm that GDP per capita appears to be the most important 
statistical factor in the cross-national variation in health care expenditure. This point leads to the 
question of how much can be explained by other factors, especially the relevance of making 
forecasts on the basis of demand-side aspects such as demographic changes. 
In Part A of the 6
th AHEAD work package (WP6) a list of variables influencing health care 
expenditure is created based on various earlier empirical studies. Additional, institutional and 
system variables are included to account for the degree of central control on total health care 
spending, economic incentives, etc. The analyses are carried out for different groups of 
countries based on the availability of data. In general, data is collected for all 25 EU countries 
and the three candidate countries, for the period 1980-2003. 
1. Variables 
The variables used for the analyses can be classified as dependant variables and explanatory 
variables: demand factors, supply factors, those factors representing the overall conditions and 
variables reflecting the health care system and the financing of health care services. 
1.1 Dependant  variables 
The aim of this part of the AHEAD project is to analyse the extent to which the development of 
health care expenditure is influenced by certain demand, supply and other factors. Thus total 
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health care expenditure can be used as a variable for the entire public and private spending on 
health care. Total health care expenditure is measured as ‘total health care expenditure per 
capita in $US PPP’. The discourse about the sustainability of health care finances does not 
generally focus on total health care expenditure, but on that for public health care alone. 
Therefore, data on public health care expenditure is collected as well as that associated with 
private payments. Private payments can be separated into out-of-pocket payments, private 
insurance distributions and contributions to other private funds.  
1.2 Demand  factors 
Total health care expenditure depends on the total number of inhabitants and the age structure of 
the population. A study for the EU-15 showed that in all countries health care expenditure 
increased with age (EPC, 2001). OECD health data provide the ratio of per capita health 
expenditure by age. Table 1 shows that the amount of health expenditure for the elderly (aged 
65+) in most countries is around three or more times the amount spent on those aged 0-64. 
Among the elderly health expenditure is higher for persons aged 75+ than for those aged 65-74. 
Table 1.Ratios of per capita expenditure by age 
Country Year  Pop.  65+  / 
pop. 0-64 
Pop. 75+ / 
pop. 0-64 
Pop. 65-74 / 
pop. 0-64 
Czech Republic 
Finland 
France 
Germany 
Portugal 
Sweden 
Switzerland 
UK 
1997 
1990 
1991 
1994 
1993 
1990 
1991 
1997 
2.80 
3.95 
2.96 
2.68 
1.70 
2.83 
4.00 
3.35 
2.98 
5.52 
3.73 
3.17 
2.14 
3.43 
5.70 
4.62 
2.69 
2.81 
2.20 
2.34 
1.40 
2.30 
2.55 
2.25 
Source: OECD Health Data (2004a). 
For the WP6 analyses the population is differentiated into the following age groups: 0-5, 6-19, 
20-34, 35-49, 50-64, 65-74, 75-84 and 85+. The ageing of the population is attributed to 
increasing life expectancies, in particular for older persons, and low fertility rates. Therefore, 
the development of these variables is also of interest. The variables are the total fertility rate, the 
life expectancy at birth and life expectancy at age 65 for both men and women. The fertility rate 
is also an indicator of births among middle-aged women, which leads to an increase in health 
care expenditures. Additionally, the number of inhabitants is influenced by migration flows. 
Thus, the net migration per 1,000 inhabitants is included in the list of variables. The health 
behaviour of migrants is different from that of citizens, and for some groups of migrants – 
especially asylum seekers – the state covers health care costs and fixes a list of provided and 
covered services. Perhaps a separate focus on citizens and foreigners may lead to better results.  
Empirical studies show that health expenditure is more related to nearness to mortality than to 
age. A crude indicator for the influence of mortality on health care expenditure could be the 
mortality rate per 1,000 inhabitants. To analyse whether such an indicator influences total health 
expenditure, the crude mortality rate is included in the data set. 
Alongside demographic variables, other demand factors affect health care expenditure. First of 
all is health status. Empirical analyses based on the European Community Household Panel 
(ECHP) have shown that health status has a significant impact on the demand for acute and 4 | ERIKA SCHULZ  
 
long-term care, and is an important driver of health expenditure (Schulz, 2004). Thus, we 
wanted to include the share of persons in good health in the analyses. 
Health behaviour is another important factor that influences health status as well as the direct 
demand for health care services. To measure health behaviour two indicators are used: alcohol 
consumption (litre per capita aged 15+) and tobacco consumption (in grams or in cigarettes per 
person per year).  
Another important variable is education. Individuals with higher levels of education show 
healthier behaviour, tend to consult a doctor more often – perhaps for prevention – and have 
fewer hospital admissions (along with a shorter length of hospital stay) (Schulz, 2004). The 
results of regression analyses based on micro data lead to the inclusion of the education level of 
a population for analyses on an aggregate level. An indicator can be the share of persons with a 
low education level – i.e. level 0/1/2 from the ISCED classification. 
Two utilisation indicators may also be included in the analyses: the number of physician 
consultations per 1,000 inhabitants and the occupancy rate of acute hospital beds. 
1.3 Supply  factors 
Providing health care services and drugs incurs costs. Therefore, several indicators for the 
volume of services provided are included in the analyses. The indicators are: physicians per 
1,000 inhabitants, in-patient care beds for acute care per 1,000 inhabitants, capacity in 
residential nursing homes/homes for the elderly, MRI scanners per million of the population, 
CT scanners per million of the population and dialyses per 100,000 inhabitants. The 
development of modern equipment and components could be an indicator for technological 
progress, which seems to be an important cost driver. 
In some cases – in particular for elective surgeries – the supply is not great enough to meet the 
demand. As a result waiting lists exist. This variable is also included to indicate the countries in 
which such restrictions exist.  
1.4 Framework  conditions 
The overall economic situation in a country determines the private and public spending on 
health care. A high living standard indicates the prosperity of a society to provide the basis for a 
broad spectrum of health care services and the application of new technologies. The living 
standard can be measured by the GDP per capita. In health care systems that are principally 
financed by taxes as well as those mainly financed by contributions to health care insurance 
schemes the amount of tax contributions depends on the added value or earnings/income. High 
economic growth rates assist the financing of public and private health care costs. 
Another indicator of the economic situation is the unemployment rate. In most health care 
insurance systems the amount of the contribution depends on the individual income of the 
insured person and therefore the contributions of unemployed persons with low incomes are less 
than those of employed persons. Thus, high unemployment rates lead to lower revenues for 
health care insurance schemes and restrict the financial scope. In addition to this direct influence 
on the premium income of health care insurers, a long period of unemployment and the absence 
of prospects for obtaining a job in the near future could lead to an adverse impact on health 
behaviour. For example, long periods of unemployment could go in line with depression and 
higher levels of alcohol consumption. Therefore, unemployment could influence the demand for 
health care services. 
Women’s labour force participation rate is mostly relevant concerning the expenditure on long-
term care. Care givers are generally women and the share of informal care givers is higher INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 5 
 
among inactive persons than their active counterparts (Schulz, 2004). It can be expected that a 
high level of women’s labour force participation reduces the possibilities for informal care-
giving and in these cases long-term care has to be provided by professional care givers at home 
or in institutions. This consequence may have an increasing effect on this kind of health care 
expenditure.  
1.5 Indictors  classifying  the health care systems 
The way in which health systems are financed affects the degree of government control over 
health spending. Most EU countries have some form of publicly financed or administered health 
insurance schemes, but in some countries tax-financed systems have been introduced to cover 
the benefit package. Private health insurance is used to fill in the gaps in the benefit package or 
to absorb out-of-pocket payments. 
Health care systems can be classified by the degree to which health care financing and delivery 
systems are publicly controlled or administered. The OECD uses three models to classify the 
systems (Docteur & Oxley, 2003): 
•  The public integrated model combines on-budget financing of health care provision with 
hospital providers that are part of the government sector. These systems are organised and 
operated like any government department. Staff are mostly public-sector employees and 
salaried. Ambulatory doctors can be either public employees or private contractors.  
•  In the public contract model, public payers contract with private health care providers. The 
payers can be either state agency or social security funds. In many public contract systems, 
private hospitals are run on a non-profit basis. Independent private contractors generally 
supply ambulatory care. 
•  The private insurance/private provider model uses private insurance combined with private 
providers. Insurance coverage can be compulsory or voluntary. Payment methods have 
traditionally been activity-based. 
A pure form of the private insurance/private provider model is not common in EU countries. In 
most countries a mix of public and private insurance and private providers exists. Private 
insurance is mostly complementary, supplementary or duplicate. Only in some countries does a 
public integrated model exist.  
In EU countries a mix of sources for health care revenues are common. Countries with systems 
that are mainly financed by taxes are Denmark, Finland, Ireland, Italy, Spain, Sweden, the UK, 
Latvia and Malta. Countries with systems that are predominantly funded by insurance 
contributions are France, Germany, Luxembourg and the Netherlands, along with new EU 
member states such as the Czech Republic, Estonia, Hungary, Poland, Slovakia and Slovenia. 
For the most part the health care revenues in Austria stem from insurance contributions, but also 
from taxation and user charges/out-of-pocket payments. Therefore, the health care system is 
basically a contract system, although it has mixed financing. A mixed system also exists in 
Belgium, Greece, Portugal, Bulgaria, Lithuania, Romania and Turkey. Cyprus has a dual system 
with a public health system financed by taxation and a private health system with user charges 
and out-of-pocket contributions. 
Table 2 shows the percentage of total expenditures on health care from taxation. In the new EU 
member states and the candidate countries the figures show the changes in the contribution of 
taxes to the financing of total health expenditure caused by changes in the political system, most 
markedly in the Czech Republic between 1992 and 1993, and in Estonia, Slovakia, Slovenia, 
Bulgaria and Romania (in different years).  6 | ERIKA SCHULZ  
 
Table 2. Percentage of total health expenditure financed by taxes 
 
In order to classify the health care systems some additional indicators are used. One indicator 
describes whether a ‘gatekeeper’ system exists. Gatekeepers are mostly general practitioners 
(GPs) or family doctors who refer the patient for secondary and/or tertiary care (to specialists 
and hospitals). It is expected that a gatekeeper system is more efficient, because the patient is 
attended by one doctor before and after secondary and tertiary care. But this scheme works only 
if the patient is obliged to visit the same primary care physician after treatment by a specialist or 
in a hospital and if the GP receives the needed information about the conducted medical 
treatments. A gatekeeper system has the aim of reducing the treatment costs by avoiding 
duplicate tests. 
Another indicator focuses on the co-payments and user charges involved in visiting a primary 
care doctor, a specialist or a dentist, or for an in-patient hospital stay or pharmaceuticals. User 
charges and co-payments are the main components of out-of-pocket payments, which along 
with private insurance contributions make up the majority of private health expenditure. User 
charges have been advocated as a source of additional revenue to slow down the necessary 
increase of taxation or contributions to fund health care services. Further, it is expected that user 
charges cap excessive demand, which can put added pressure on already escalating expenditures 
for covered health services. But on the other hand, user charges disproportionately affect lower 
income groups through changes in their utilisation of services. In Germany, for example, 
No Countries 1980 1985 1987 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
1 Austria 13,5 12,6 13,2 13,7 13,8 13,9
2 Belgium 39 38
3 Denmark 86,5 85 83,4 82,8 82,3 82
4 Finland 67,1 70,3 62,2 61,9 61,9 61,5 60,8
5 France
1) 4,3 3,6 2,3 2,2 2,1 2,1 2,3 2,4 2,4 2,5 2,5 2,5 2,6 2,7 2,4
6 Germany 13 12,9 10,8 8,1 8 7,9 7,8 7,8
7G r e e c e 4 0 3 0
8 Ireland
1) 71,1 72,2 70,6 72,3 71 70,7 70,5 73,8 75,7 72 72,4 74,9 74,6
9 Italy 80,5 77,2 78,1 67,7 67,8 68 68 67
10 Luxembourg 20,9 14,7 15,4 14,8
11 Netherlands 9 11 10 4,8 5,2 5,6
12 Portugal 65,5 62,8 59,6 63 63,4 61,7 64,8 67,9 68,5 69
13 Spain 70 98
14 Sweden 77,7
15 UK 80,1 77,5 78,8 81,8 82 82,4 82,1 81,5
16 Cyprus no information
17 Czech Republic 96,8 95,4 19,1 16,5 16,5 12,5 11,8 10,9 11,1 10,5 9,5 10,2
18 Estonia 100 10,9 10,8 10,7
19 Hungary 16,1 18,6 16,8 14 13,1 12,7 12,2
20 Latvia 78,9 78,9
21 Lithuania 7,4
22 Malta dual system, no infromation about the share of taxed based financing on total health expenditure
23 Poland 100 94 70 76 73
24 Slovakia 34,0 31,3 24,5 5,2 5,0 4,4 3,2
25 Slovenia 98,5 2,6 2,8 3,4 3,4 3,3
26 Bulgaria 100 98 100 100 69,2
27 Romania 100 100 100 100 100 100 100 100 36,2 21,6
28 Turkey 46,1 46,7 46 43,1 43,1 43,4 40,4
Sources: HIT reports
1) OECD data: health care expenditure from general government excluding social security on total HCE .INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 7 
 
increased user charges and co-payments for pharmaceuticals and medical aids have led to a 
reduction in doctor visits, especially by low-income patients (elderly persons and those with 
chronic diseases) although the total yearly co-payments are limited (2% and 1% respectively of 
the yearly income). Therefore, it could be that high user charges slows down the increase in 
total health care expenditure.  
Table 3 shows the proportion of out-of-pocket payments in total health expenditure. Countries 
that have systems with a high share of out-of-pocket payments are Spain, Hungary, Poland and 
Turkey. 
Table 3. Household out-of-pocket payments
*) as a percentage of total health expenditure 
 
In many EU countries there is a supplementary or complementary private health-insurance 
system. Reductions in the statutory health benefits package in these systems tend to lead to an 
increase in supplementary, voluntary health-insurance contributions to cover the non-statutory 
services (for example co-payments for prostheses). Contributions to private insurance schemes 
are, along with out-of-pocket payments, another large part of private health expenditure. 
The reimbursement systems of physicians and hospitals are also used to characterise the health 
care system. The way in which hospitals are remunerated sets different incentives for their 
financial management. A prospective global budget based on past performance for hospitals 
could be a tool for cost containment, if the global budget is fixed (with a ceiling on hospitals). 
Countries 1980 1985 1990 1995 1996 1997 1998 1999 2000 2001 2002 2003
1 Austria 14,9 15,6 17,6 17,9 18,2 18,6 18,2 17,5
2 Belgium
3 Denmark 11,4 13,6 16,0 16,3 16,2 16,3 16,6 16,1 15,9 15,8 15,8 15,8
4 Finland 18,4 18,3 15,5 20,5 20,3 19,7 19,4 20,3 20,4 20,2 20,0 19,0
5 France 12,8 14,4 11,4 10,8 10,5 10,3 10,3 10,3 10,5 10,2 9,8 10,0
6 Germany 10,3 11,2 11,1 10,0 10,1 10,8 11,2 10,9 10,5 10,6 10,4 10,4
7 Greece 44,9 43,6 46,0 46,5
8 Ireland -9   14,4 16,5 15,5 14,6 13,5 10,7 14,0 13,5 11,9 13,2
9 Italy -9   -9   15,3 24,4 24,2 24,1 24,5 24,1 22,8 20,3 20,4 20,7
10 Luxembourg 7,2 9,2 5,5 6,2 7,2 7,5 7,6 7,4 7,5 7,5 11,9
11 Netherlands 8,4 9,0 9,0 8,7 8,0 7,8
12 Portugal
13 Spain 23,5 23,2 23,1 23,2 23,3 23,7 23,8 23,6 23,7
14 Sweden
15 United Kingdom 8,6 -9   10,6 10,9 11,0
16 Cyprus
17 Czech Republic 2,6 7,3 7,5 8,3 8,1 8,5 8,6 8,6 8,4 8,4
18 Estonia
19 Hungary 16,0 18,4 18,7 22,3 24,9 26,3 27,7 26,3
20 Latvia
21 Lithuania
22 Malta
23 Poland 8,3 27,1 26,6 28,0 34,6 28,9 30,0 28,1 27,6
24 Slovakia 8,3 8,4 10,4 10,6 10,7 10,9 11,7
25 Slovenai
26 Bulgaria
27 Romania
28 Turkey 29,7 30,8 29,1 27,6
*) Household out-of-pocket expenditure comprise cost-sharing, self-medication and other expenditure paid 
directly by private households, irrespective of whether the contact with the health care
system was established on referral or on the patient's initiative.
Source: OECD Health Data 2004 and 2005.8 | ERIKA SCHULZ  
 
But the incentives for cost control are limited if the budget is retrospectively calculated on a 
full-cost basis. Critics claim that a global budget system is inflexible – that it does not reward 
more efficient departments and sets no incentives for better organisation within a hospital or 
more effective treatments. Remuneration on a per diem basis encourages increases in the 
hospital stays of patients. The most effective remuneration seems to be a diagnosis-related 
group (DRG) payment system. More and more countries are changing their hospital 
reimbursement system to a DRG-based method. 
Other variables describing the health care system are the free choice of physicians and hospitals 
and the existence of waiting lists for specialist treatments or elective surgeries in hospitals. A 
free choice of physicians and hospitals is associated with two contrasting effects. One argument 
is that free choice stimulates competition among physicians and hospitals and will therefore 
have a slowing-down effect on health expenditure. Another argument is that free choice leads to 
more doctor visits and duplicate treatments because patients change physicians more often if 
they have the opportunity. 
Waiting times for elective surgery are a main health policy concern in approximately half of the 
OECD countries (Hurst & Sicilliani, 2003). Mean waiting times for elective surgeries are above 
three months in several countries and maximum waiting times can stretch into years. Waiting 
times can lead to deterioration in health, loss of utility and extra costs. Waiting lists are mostly 
found in countries that combine public health insurance, low or no patient cost-sharing and 
constraints on surgical capacity. In these cases waiting lists are used as non-price rationing. But 
they generate high dissatisfaction among patients. Many countries take steps to reduce long 
waiting lists for elective surgery. Some have increased the capacity for surgery while others 
have combined maximum waiting-time targets with additional activity and changed incentives. 
In many cases improvements in the efficiency of surgical units could be implemented. 
Nevertheless, at present waiting lists exist in Denmark, England, Finland, Ireland, Italy, the 
Netherlands, Portugal, Spain, Sweden, Hungary, Malta and Slovenia. 
2  Data sources, availability and comparability across countries 
2.1 Data  sources 
Data have been collected for all 25 EU member states and the 3 candidate countries for (where 
possible) the period 1980-2003. The main data source for the health care expenditure, demand 
and supply factors has been the OECD’s Health Data 2004. For those countries with no 
information in this database the WHO’s European Health for All Database has been used. In 
some cases missing data in the OECD time series between 1980 and 2003 have been filled in 
with WHO data, if this has seemed to fit in the time series. Population data stem from 
EUROSTAT. The indicators describing health care and the financing systems are author-created 
variables based on a review of the literature. The Health Care Systems in Transition reports 
from the European Observatory on Health Systems and Politics have provided the main 
information for individual countries; additional relevant literature has also been used, such as 
the MISSOC, MISSCEEC and other papers from the European Commission, along with OECD 
data and reports.  
2.2 Data  availability 
The OECD Health Data 2004 covers 19 EU countries: the EU-15 and the Czech Republic, 
Hungary, Poland and the Slovak Republic. In the new version of the data set for 2005, 
information about the health care expenditure of the non-OECD EU member states (Estonia, 
Lithuania, Latvia, Malta, Slovenia and Cyprus) for the year 2002 is also included. The OECD is 
used as the main database for health care expenditure, education, consultations with doctors, the INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 9 
 
supply of health care services (physicians per 1,000 inhabitants, physicians per 100 hospital 
beds, acute-care beds per 1,000 inhabitants, MRI scanners per million inhabitants, CT scanners 
per million inhabitants and dialyses per 100,000 inhabitants), the acute-care occupancy rate, the 
population covered by the public health care system, GDP per capita in $US PPP and women’s 
labour force participation rates. Where it has seemed possible, the OECD data have been 
combined with information from the WHO European Health for All Database for the non-
OECD EU member states. Additionally, the WHO database has been used for life expectancies 
at birth and at age 65, as well as for the crude mortality rate, the health behaviour (alcohol and 
tobacco consumption) and for nursing and elderly home beds per 100,000 inhabitants. 
Population data stem from Eurostat. For the EU-15 information is mostly available for period 
1980 to 2002-03. Data for the new member states are generally available from the beginning of 
the 1990s, but population and supply data are often available for longer periods (1980 or 1985 
to 2002-03). OECD health data have also provided information about the share of the 
population in good health, but only for some countries and for certain years (different per 
individual country). Therefore, it has not been possible to integrate this variable into the data 
set. Another problem has been the lack of sufficient data for Cyprus and Malta.  
2.3  Data comparability across countries 
The OECD has the responsibility of ensuring that the data presented in the Health Data 2004 
report are as comparable as possible across countries and over time. To improve the quality of 
international comparisons, the System of Health Accounts (SHA) was published in May 2000 
with guidelines for reporting health expenditure. Total expenditure on health in the SHA is 
defined as the sum of expenditures on activities that have the goal of: 
•  promoting health and preventing disease; 
•  curing illness and reducing premature mortality; 
•  caring for persons affected by chronic illness who require nursing care; 
•  caring for persons with health-related impairments, disabilities and handicaps who require 
nursing care; 
•  assisting patients to die with dignity; 
•  providing and administering public health; and 
•  providing and administering health programmes, health insurance and other funding 
arrangements. 
Therefore, the SHA includes: 
•  services of curative care (HC.1); 
•  services of rehabilitative care (HC.2); 
•  services of long-term nursing care (HC.3); 
•  ancillary services to health care (HC.4); 
•  medical goods dispensed to out-patients (HC.5); 
= total expenditure on personal health (HC.1-HC.5); 
•  services of prevention and public health (HC.6); 
•  health administration and health insurance (HC.7); 
= total expenditure on collective health (HC.6+HC.7); 
= total current expenditure (HC.1-HC.7); 
•  investment in health (HC.R.1); 
= total expenditure on health (HC.1-HC.7+HC.R.1). 10 | ERIKA SCHULZ  
 
OECD member countries are at varying stages of reporting total health expenditure according to 
the definition of the SHA. In general the data fall into four groups: 
The first group of countries closely follows the SHA definition just described. These are: 
Denmark, France, Germany, Hungary, the Netherlands, the UK, Spain and Turkey. 
The second group has locally produced health accounts, which are similar to the SHA: Finland 
and Poland. 
The third group has national accounts with numerous problems for international comparisons, 
such as: 
•  the level of detail is often minimal; 
•  certain elements of health care expenditure are reported as social services (which leads to 
underestimations of overall health expenditure) and most occupational health care is not 
reported in national accounts; 
•  the national accounts are not precise in defining what is included in health care; 
•  the availability of data on private health care expenditure is limited; and 
•  details on data sources and estimation methods are usually not published.  
This third group of countries comprises Austria, the Czech Republic, Greece, Ireland, Italy, 
Luxembourg, Portugal, the Slovak Republic and Sweden. 
Finally, Belgium comprises a fourth group, for which estimates are made by the OECD 
Secretariat based on the OECD National Account database.  
In most countries there are breaks in the time series owing to changes in the reporting system, 
i.e. changes from national accounts (NA) or National Accounts Estimates (NAE) to SHA 
accounts, as follows for the country groups discussed above: 
Group I – Germany 1970-90 (NA), 1992-2002 (SHA); Hungary 1991-97 (NA), 1998-2002 
(SHA); the Netherlands 1972-1998 (NA), 1998-2001 (SHA); the UK 1960-96 
(NAE), 1997-2002 (SHA); Spain 1960-98 public expenditure (NA) and private 
expenditure (NAE), 1999-2002 (SHA); and Turkey 1970-97 (OECD estimates), 
1998 (NA), 1999-2000 (SHA). 
Group III – Greece 1970, 1980 (OECD estimates), 1987-2002 (NAE); Portugal 1970-94 (OECD 
estimates), 1995-2002 (NAE). 
The data on total health expenditure for the remaining countries (Cyprus, Estonia, Latvia, 
Lithuania, Malta, Slovenia, Bulgaria and Romania) stem from the WHO database. These 
countries reported the data directly. Health expenditure in some of these countries, particularly 
in the Eastern European ones, is likely to be underestimated, owing to the exclusion of the 
private sector and out-of-pocket payments (WHO, 2003, p. 98). But in the remaining new 
member states and candidate countries, for the most part some information about private health 
care expenditures is available as outlined below:  
•  Romania – private expenditure is only available for 1996 (4.1% of total health expenditure 
or THE); 
•  Slovenia – there is information about voluntary health insurance (11.6% of THE in 1998), 
but there is no data about direct payments;  
•  Lithuania – information about private health care expenditure exists (which was around 
23% of THE in 1998);  INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 11 
 
•  Latvia – different estimations about the level of out-of-pocket payment exist (e.g. estimated 
as 39% in 2000 by the WHO, 7-10% by the Ministry of Welfare and 21% for the period 
1998-99);  
•  Bulgaria – only WHO estimates are available for out-of-pocket payments (18% in 2000);  
•  Estonia – information about out-of-pocket payments and private health insurance exists 
starting from 1999 (private health insurance in 2002 was around 24% of THE);  
•  Cyprus – a study offers information about out-of-pocket payments (around 4% of median 
household income in 2002); and  
•  Malta – while no co-payments are required for public health care, for private care out-of-
pocket and private insurance payments do occur, but no exact data are available. 
Health expenditure and financing data are the most important aspects in the data set, and use of 
the OECD health data ensures the most comparable data in this field. Data about population and 
age structure seem to be fully comparable and in any case Eurostat did not report any problems. 
Nor did the OECD report any problems for the other supply and demand factors.  
The author-generated variables classifying the health care systems stem mainly from the Health 
Care Systems in Transition (HiT) reports from the European Observatory on Health Systems 
and Politics. The Observatory is a partnership among the WHO Regional Office for Europe, the 
governments of Belgium, Finland, Greece, Norway, Spain and Sweden, the Veneto Region of 
Italy, the European Investment Bank, the Open Society Institute, the World Bank, CRP-Santé 
Luxembourg, the London School of Economics and Political Science (LSE) and the London 
School of Hygiene & Tropical Medicine (LSHTM). The HiT profiles are produced by country 
experts in collaboration with the research directors and staff of the Observatory. In order to 
maximise comparability among countries, a standard template and questionnaire have been 
used. These provide the detailed guidelines and specific questions, definitions and examples 
needed to compile the HiT. Notes about the methodology used by the Observatory are reported 
on its website homepage as follows: 
Compiling the HiT profiles poses a number of methodological problems. In many 
countries, there is relatively little information available on the health care system and the 
impact of reforms. Most of the information in the HiTs is based on material submitted by 
experts in the respective countries, which is then reviewed by independent experts. 
Nonetheless, some statements and judgements may be coloured by personal interpretation. 
In addition, the absence of a single agreed terminology to cover the wide diversity of 
systems in the European Region means that variations in understanding and interpretation 
may occur. A set of common definitions has been developed in an attempt to overcome this, 
but some discrepancies may persist. These problems are inherent in any attempt to study 
health care systems on a comparative basis. (Retrieved from 
www.euro.who.int/observatory/Hits.) 
Nevertheless, using the information from these reports seems to provide the most comparable 
analyses of the health care systems in the member states.  
2.4  Basic data set for further analyses 
The variables included in the basic data set and the time periods are shown in Table 4. With the 
exception of the self-reported health status, all the required information could be collected and 
introduced. In some cases missing years could be filled in by interpolation of data.  12 | ERIKA SCHULZ  
 
Table 4. Basic data set 
Countries
Variable
HEALTH CARE EXPENDITURE
HCE US$ PPP  (in million) 1980,85,90-2002 1980-90,92-2002 1980,87-2002
HCE US$ PPP per capita 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Public expenditure  US$ PPP (in million) 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2003 1980,87-2003
Public expenditure US$ PPP per capita 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2003 1980,87-2002
Public expenditure as % of total HCE (US$ PPP per capita) 1980-2002 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Private payment as % of total HCE 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Out-of-pocket payments (household) as % of total HCE 1995-2002 1980,85,90-2002 1980-90,92-2002
Private insurance as % of total HCE 1980-2002 1980,85,90-2002 1980-90,92-2002
All other privat funds as % of total HCE 1995-2002 1980,85,90-2002 1980-90,92-2002
DEMAND FACTORS
Population
total population at 1. January
foreigners as share of total population 1980-2001 1981-2001 1982,90,99 1980-2001 2001
age-composition as share of total
0-5,6-19,20-34,35-49,50-64,65-74,75-84,85+
life expectancy at birth 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  male 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  female 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
life expectancy at 65 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  male 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  female 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
total fertility rate  1980-2002 1980-2002 1980-2002 1980-2002 1980,83,85-2001 1980,90-2001 1980,83,89-2001
migration per 1000 inhabitants
crude death rate per 1000 population 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
Other demand factors 
health status (share of people in bad health)
health behaviour: alcohol consumption 1990-2001 1980-2001
health behaviour: tobacco consumption 1990-2000 1980-2000
education level - attainment ISCED 0/1/2 1989-2002 1989-2002 1990-2002 1989-2002 1989-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 3/4 1989-2002 1989-2002 1990-2002 1989-2002 1989-92,94-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 5B 1993-2002 1989-2002 1990-2002 1989-2002 1989-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 5A/6 1989,91-2002 1989,91-2002 1991-2002 1989,91-2002 1989,91-2002 1989,91-2002 1990-91,93-2002
Utilisation of health care services
doctor's consultation per capita 1980-2002 1980-2002 1980-87,89-2002 1980-2002 1980-2001 1990-2000 1980-98
SUPPLY FACTORS
Supply of health care services
physicians per 1 000 inhabitants 1980-2002 1980-2002 1980-82,84-2002 1980-2002 1980-2002 1990-2002 1980-2001
physicians per 100 hospital beds 1980-2002 1983-2001 1980-82,84-2001 1986-2002 1990-2001 1991-2001 1980-96,99-2000
acute care beds per 1 000 inhabitants 1980-2002 1980-1997 1980-2001 1980-2003 1980-2001 1991-2001 1980,84-85,89-2000
acute care occupancy rate % of available beds 1981-2002 1980-1998 1980-2001 1984-95 1980-2001 1980-2001 1980-99
nursing and elderly home beds per 100 000 inhabitants 1990-2002 1986,88-97 1980-2002 1980-2001 1990-97,99,2001 1980-89
MRI (and CT scanners) per million inhabitants 86-89,91-93,95-02 1989-90,93-97 1989-90,98-2002 1983-2002 1986-2001 1990-2001 1989-92,96-98,2001-02
(MRI and) CT scanners per million inhabitants 86-90,92-93,95-02 1989-90,93-94 1980-2002 1980-2002 1984-2001 1990-2001 1980,84-85,89-92,96-97,2001-02
dialyses per 100 000 inhabitants 1980-2002 1980-94 1980-2002 1980-2002 1980-95,2000-01 1980-2002 1980-2002
France Greece
1980-2001
1980-2000
Germany
1980/84,1985/89,1990/94,1995/99,2000-02
1980-2003
1980-2001
1980-2003
Austria Belgium Denmark Finland
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
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Table 4. Continued 
Countries
Variable
HEALTH CARE EXPENDITURE
HCE US$ PPP  (in million) 1980,85,90-2002 1980-90,92-2002 1980,87-2002
HCE US$ PPP per capita 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Public expenditure  US$ PPP (in million) 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2003 1980,87-2003
Public expenditure US$ PPP per capita 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2003 1980,87-2002
Public expenditure as % of total HCE (US$ PPP per capita) 1980-2002 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Private payment as % of total HCE 1980-2002 1995-2002 1980,85,90-2002 1980-90,92-2002 1980,87-2002
Out-of-pocket payments (household) as % of total HCE 1995-2002 1980,85,90-2002 1980-90,92-2002
Private insurance as % of total HCE 1980-2002 1980,85,90-2002 1980-90,92-2002
All other privat funds as % of total HCE 1995-2002 1980,85,90-2002 1980-90,92-2002
DEMAND FACTORS
Population
total population at 1. January
foreigners as share of total population 1980-2001 1981-2001 1982,90,99 1980-2001 2001
age-composition as share of total
0-5,6-19,20-34,35-49,50-64,65-74,75-84,85+
life expectancy at birth 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  male 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  female 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
life expectancy at 65 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  male 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
  female 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
total fertility rate  1980-2002 1980-2002 1980-2002 1980-2002 1980,83,85-2001 1980,90-2001 1980,83,89-2001
migration per 1000 inhabitants
crude death rate per 1000 population 1980-2002 1980-97 1980-99 1980-2002 1980-2000 1990-2001 1980-2001
Other demand factors 
health status (share of people in bad health)
health behaviour: alcohol consumption 1990-2001 1980-2001
health behaviour: tobacco consumption 1990-2000 1980-2000
education level - attainment ISCED 0/1/2 1989-2002 1989-2002 1990-2002 1989-2002 1989-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 3/4 1989-2002 1989-2002 1990-2002 1989-2002 1989-92,94-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 5B 1993-2002 1989-2002 1990-2002 1989-2002 1989-2002 1989-2002 1990-91,93-2002
education level - attainment ISCED 5A/6 1989,91-2002 1989,91-2002 1991-2002 1989,91-2002 1989,91-2002 1989,91-2002 1990-91,93-2002
Utilisation of health care services
doctor's consultation per capita 1980-2002 1980-2002 1980-87,89-2002 1980-2002 1980-2001 1990-2000 1980-98
SUPPLY FACTORS
Supply of health care services
physicians per 1 000 inhabitants 1980-2002 1980-2002 1980-82,84-2002 1980-2002 1980-2002 1990-2002 1980-2001
physicians per 100 hospital beds 1980-2002 1983-2001 1980-82,84-2001 1986-2002 1990-2001 1991-2001 1980-96,99-2000
acute care beds per 1 000 inhabitants 1980-2002 1980-1997 1980-2001 1980-2003 1980-2001 1991-2001 1980,84-85,89-2000
acute care occupancy rate % of available beds 1981-2002 1980-1998 1980-2001 1984-95 1980-2001 1980-2001 1980-99
nursing and elderly home beds per 100 000 inhabitants 1990-2002 1986,88-97 1980-2002 1980-2001 1990-97,99,2001 1980-89
MRI (and CT scanners) per million inhabitants 86-89,91-93,95-02 1989-90,93-97 1989-90,98-2002 1983-2002 1986-2001 1990-2001 1989-92,96-98,2001-02
(MRI and) CT scanners per million inhabitants 86-90,92-93,95-02 1989-90,93-94 1980-2002 1980-2002 1984-2001 1990-2001 1980,84-85,89-92,96-97,2001-02
dialyses per 100 000 inhabitants 1980-2002 1980-94 1980-2002 1980-2002 1980-95,2000-01 1980-2002 1980-2002
France Greece
1980-2001
1980-2000
Germany
1980/84,1985/89,1990/94,1995/99,2000-02
1980-2003
1980-2001
1980-2003
Austria Belgium Denmark Finland
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-2002
1980-200214 | ERIKA SCHULZ  
 
Table 4. Continued 
Countries
Variable
HEALTH CARE EXPENDITURE
HCE US$ PPP  (in million) 1980-2002 1988-2003
HCE US$ PPP per capita 1980-2002 1988-2002
Public expenditure  US$ PPP (in million) 1980-2002 1988-2003 1980-2002 1980-97
Public expenditure US$ PPP per capita 1980-2002 1988-2002 1980-2002 1980-97
Public expenditure as % of total HCE (US$ PPP per capita) 1980-2002 1988-2003 1980-2002 1980-97
Private payment as % of total HCE 1980-2002 1988-2003 1980-2002 1980-97
Out-of-pocket payments (household) as % of total HCE 1983-2002 1988-2003 1980-2002 1998-2002 1991-2002 1980,90-96
Private insurance as % of total HCE 1989-2002 1990-2003 1999-2002 1998-2002 1981-97 1980-2002 1980-96
All other privat funds as % of total HCE 1989-2002 1988-2003 1999-2002 1999-2002 1995-99 1991-2002 1990-96
DEMAND FACTORS
Population
total population at 1. January 1980-2003 1980-2001 1980-2001
foreigners as share of total population 1986-2001 1988-2001 1986-2001 1980-2001 1984-2001
age-composition as share of total
0-5,6-19,20-34,35-49,50-64,65-74,75-84,85+
life expectancy at birth 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
 male 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
 female 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
life expectancy at 65 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
 male 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
 female 1980-2001 1980-2001 1980-2002 1980-2000 1980-2002 1980-2001 1980-2001 1980-2002
total fertility rate  1980-2002 1980-2001 1980-2002 1980,83,89-2002 1980-81,83,85-2001 1980,83,89-95,97-2001 1980-2002 1980-2001
migration per 1000 inhabitants
crude death rate per 1000 population 1980-2002 1980-2000 1980-2002 1980-2002
Other demand factors 
health status (share of people in bad health)
health behaviour: alcohol consumption 1980-1996
health behaviour: tobacco consumption 1981-2000
education level - attainment ISCED 0/1/2 1989-2003 1989-2002 1994-96,98-2002 1989-2002 1989-91,93-2002 1989-2002 1989-2002 1989-2002
education level - attainment ISCED 3/4 1989-2003 1989-2002 1994-96,98-2002 1989-2002 1989-91,93-2002 1989-2002 1989-2002 1989-2002
education level - attainment ISCED 5B 1989-2003 1998-2002 1989-91,98-2002 1989-91,93-2002 1991-2002 1989-96,99-2002 1989-2002
education level - attainment ISCED 5A/6 1989,91-2003 1989,91-2002 1994-96,98-2002 1989-96,98-2002 1989-91,93-2002 1989,91-2002 1989,91-2002 1989,91-2002
Utilisation of health care services
doctor's consultation per capita 1980-88,90-91,93-94,98-2000 1995-2002 1980-2002 1980-2001 1986-87,92-97,2000-01 1980-2001 1980-2000
SUPPLY FACTORS
Supply of health care services
physicians per 1 000 inhabitants 1991-2002 1980,83-2001 1980-2002 1980-91,97-02 1980-2002 1998-2002 1980-2000 1980-99,2001-02
physicians per 100 hospital beds 1980-81,83-2001 1984,86-88,90-2001 1983-2001 1983-91,98-2001 1980-2001 1989-98,2000 1980-97 1980-81,85-93
acute care beds per 1 000 inhabitants 1980-2002 1980-2001 1980,84-02 1980-2001 1980-2001 1995-2002 1980-2000 1980-2002
acute care occupancy rate % of available beds 1980-2002 1980-2001 1980,84-85,87-94,98-2002 1980-2001 1984-2001 1983-2000 1980-96 1980-86,94-2001
nursing and elderly home beds per 100 000 inhabitants 1980-90,94-98,2000-02 1986-97 1990-2001 1980,85-98 1980-99 1980-99
MRI (and CT scanners) per million inhabitants 1989-2002 1989-2002 1985-95 1989-90,96-97 1983-84,87-88,91-2002 1983-95,98-99 1985-95,98-2002
(MRI and) CT scanners per million inhabitants 1985-86,89-90 1989-2002 1989-90,93-2002 1980-81,83-84,89-93 1989-90,96-97 1983-94,87-88,91-2002 1980-93,98-99 1985-90,92-93,97-2002
dialyses per 100 000 inhabitants 1980-95 1980-95 1993-2002 1980-96 1980-91,96-2002 1980-99 1980-95 1980-91,94-95,97-98,2000-02
Ireland
1980-2003
1980-2001
UK Italy Luxembourg Netherlands Portugal
1980-2003
Spain Sweden
1980-2000 1980-2000 1980-2000
1980-2001 1980-2001
1980-2002
1980-2002
1980-2001 1980-2001
1980-2001 1986-2003
1980-2002
1980-2002
1980-2002
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Table 4. Continued 
Countries
Variable
HEALTH CARE SYSTEM
Organisational structure
Health care system (public contract, public integrated, mixed) 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Gatekeeper to non-acute hospital treatment or specialist 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Free choice GP or family doctor 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Free choice of specialists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Free choice of hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Free choice of dentists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Waiting lists for specialist care 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
waiting lists for surgeries in hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Financing the health care system
Population covered by public health system % of total population 1980-2000 1980-97 1980-83,92-2002 1980-2001 1980-2002 1980-97 1980-2003 1980-2002
Multiple or single source financing system 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
population covered by privates health insurance 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with GP visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with specialists visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with hospital admission 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payments in connection with dentist care 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co.payments for pharmaceuticals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Reimbursement of hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(global budget, fee-for-service, per diem, per discharge)
Reimbursement of physicians in hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, fixed salary)
Reimbursement of general practitioner  1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of specialists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of dentists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Overall ceiling of hospital expenditure 1980-2003 1980-2003
FRAMEWORK CONDITIONS
Gross domestic product per capita, US$ PPP
female labour force participation (18-65?)
unemployment rate  in % of labor force 1980-2002 1980-2001 1980-2002 1980-2002 1980-2002 1980-2000 1980-2002 1980-2000
Sources:
EUROSTAT
OECD health Data 2004, Version 1
European health for all database, WHO Regional Office for Europe, Copenhagen, Denmark.
Own created variables based on literatur review
1980-2002
UK Italy Luxembourg Netherlands Portugal Spain Sweden Ireland
1980-200216 | ERIKA SCHULZ  
 
Table 4. Continued 
Countries
Variable
HEALTH CARE EXPENDITURE
HCE US$ PPP  (in million) 2001 1990-2002 1992-95,98-2001 1991-2002 1999-2001
HCE US$ PPP per capita 2001 1990-2002 1992-95,98-2001 1991-2002 1999-2001
Public expenditure  US$ PPP (in million) 2001 1990-2002 1998-2001 1991-2002 1999-2001
Public expenditure US$ PPP per capita 2001 1990-2002 1998-2001 1991-2002 1999-2001
Public expenditure as % of total HCE (US$ PPP per capita) 1980-2001 1980,85,89-2002 1996-2002 1991-2002 1990-2002 1987-2002 1999-2002
Private payment as % of total HCE 1980,85,89-2002 1991-2002
Out-of-pocket payments (household) as % of total HCE 1990-2002 1991-2002
Private insurance as % of total HCE 1998-2002
All other privat funds as % of total HCE 1998-2002
DEMAND FACTORS
Population
total population at 1. January 1980-2002
foreigners as share of total population 1992-2001 1994-97,99-2001
age-composition as share of total
0-5,6-19,20-34,35-49,50-64,65-74,75-84,85+
life expectancy at birth 1999-2001 1980-84.86-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
  male 1999-2001 1980-84.86-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
  female 1999-2001 1980-84.86-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
life expectancy at 65 1999-2001 1986-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
  male 1999-2001 1986-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
  female 1999-2001 1986-2002 1981-82,85-2002 1980-2002 1980-2002 1980-2002 1980-2002
total fertility rate  1980-2001 1980-2002 1980-2002 1980,83,89-2002 1980,85-2002 1980-2002 1985-2002
migration per 1000 inhabitants
crude death rate per 1000 population 1999-2001 1980-84,86-2002 1981-82,85-2002 1981-2002 1980-2002
Other demand factors 
health status (share of people in bad health)
health behaviour: alcohol consumption 1992-2001 1984-90,92,95-2001 1988-2001
health behaviour: tobacco consumption 1993-98 1995-96 1980-97,99-2000 1995-2000 1980-83
education level - attainment ISCED 0/1/2 1993-2002 1995-2002
education level - attainment ISCED 3/4 1993-2002 1995-2002
education level - attainment ISCED 5B 1999-2002
education level - attainment ISCED 5A/6 1993-2002 1995-2002
Utilisation of health care services
doctor's consultation per capita 1980-2002 1993-2002
SUPPLY FACTORS
Supply of health care services
physicians per 1 000 inhabitants 1980-2001 1994-2002 1980,85-2002 1980-2002 1980,85-2002 1980-2002 1981-82,84,87-93,97-2000,02
physicians per 100 hospital beds 1980-2001 1980-2002 1980,85-2002 1981-83,85-99,2002 1980,1985-2002 1980-2002 1984,87-89,93,97-2000,02
acute care beds per 1 000 inhabitants 1980-2001 1984-2000 1980,85-2002 1980-2002 1998-2002 1992-2002 1997-2002
acute care occupancy rate % of available beds 1980-2001 1980-2002 1980,85-2002 1980-2002 1992-2002 1997-2002
nursing and elderly home beds per 100 000 inhabitants 1980-2002 1996-2002 1980-94,96-2002 1990-2002 2002
MRI (and CT scanners) per million inhabitants 1990-2002 1984-2002
(MRI and) CT scanners per million inhabitants 1990-2002 1980-2002
dialyses per 100 000 inhabitants 1980-95 1980-96
1990-95,97-2001
1990-95,97-2001
1990-95,97-2001
1980,85,89-2003 1980,85,90-2003 1980,85,90-2003
1990-95,97-2001
1980-2001
1980-2002
1980-2001
1989,2000-03 1980,85,90-2003 2000-2002
Estonia Hungary
1980/84,1985/89,1990/94,1995/99,2000-02
Latvia Lithuania Malta Cyprus Czech Republic
1980-2003
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Table 4. Continued 
Countries
Variable
HEALTH CARE SYSTEM
Organisational structure
Health care system (public contract, public integrated, mixed) 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Gatekeeper to non-acute hospital treatment or specialist 1980-2003 1980-2003 1998-2003 1992-2003 1992-2003 1990-2003 1980-2003
Free choice GP or family doctor 1980-2003 1993-2003 1992-2003 1992-2003 1980-2003 1991-2003 1980-2003
Free choice of specialists 1980-2003 1993-2003 1992-2003 1992-2003 1980-2003 1991-2003 1980-2003
Free choice of hospitals 1980-2003 1993-2003 1992-2003 1992-2003 1992-2003 1991-2003 1980-2003
Free choice of dentists 1980-2003 1993-2003 1992-2003 1992-2003 1991-2003 1991-2003 1980-2003
Waiting lists for specialist care 1980-2003 1980-2003 1992-2003 1991-2003 1991-2003 1991-2003 1980-2003
waiting lists for surgeries in hospitals 1980-2003 1980-2003 1992-2003 1990-2003 1991-2003 1991-2003 1980-2003
Financing the health care system
Population covered by public health system % of total population 1980-2002 1980-2002
Multiple or single source financing system 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
population covered by privates health insurance 1980-2003 1993-2003 1993-2003 1992-2003 n.a. 1991-2003 n.a.
Co-payment in connection with GP visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with specialists visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with hospital admission 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payments in connection with dentist care 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co.payments for pharmaceuticals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Reimbursement of hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(global budget, fee-for-service, per diem, per discharge)
Reimbursement of physicians in hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, fixed salary)
Reimbursement of general practitioner  1980-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of specialists 1980-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of dentists 1980-2003 1993-2003 1992-2003 1980-2003 1980-2003 1991-2003 1980-2003
(fee-for-service, salary, capitation)
Overall ceiling of hospital expenditure 1992-2003 1990-2003 1991-2003 1980-2003
FRAMEWORK CONDITIONS
Gross domestic product per capita, US$ PPP
female labour force participation (18-65?)
unemployment rate  in % of labor force 1980-2001 1990-2002 1989-2002 1990-2002 1992-2002 1991-2002 1983,85-2002
Sources:
EUROSTAT
OECD health Data 2004, Version 1
European health for all database, WHO Regional Office for Europe, Copenhagen, Denmark.
Own created variables based on literatur review
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Table 4. Continued 
Countries
Variable
HEALTH CARE EXPENDITURE
HCE US$ PPP  (in million) 1990-2002 1997-2002 1989-2001 1988-1994 1988-90,92-2001 1980-2000
HCE US$ PPP per capita 1990-2002 1997-2002 1989-2001 1988-1994 1988-90,92-2001 1980-2000
Public expenditure  US$ PPP (in million) 1990-2002 1997-2002 1989-2001 1988-1994 1988-90,92-2001 1980,84-2000
Public expenditure US$ PPP per capita 1990-2002 1997-2002 1989-2001 1988-1994 1988-90,92-2001 1980,84-2000
Public expenditure as % of total HCE (US$ PPP per capita) 1990-2002 1997-2002 1980,85-2001 1988-1994 1985-2001 1980,84-2000
Private payment as % of total HCE 1990-2002 1997-2002 1980,84-2000
Out-of-pocket payments (household) as % of total HCE 1990-2002 1997-2002 1992-96,99-2000
Private insurance as % of total HCE 1996-98 1984-87,91,94,99-2000
All other privat funds as % of total HCE 1999-2000
DEMAND FACTORS
Population
total population at 1. January 1985-2003
foreigners as share of total population 1999 1993-2001
age-composition as share of total
0-5,6-19,20-34,35-49,50-64,65-74,75-84,85+
life expectancy at birth 1980-2002 1980,82,84-2002 1985-2002 1980-2002 1980-2002 1980-2001
  male 1980-2002 1980,82,84-2002 1985-2002 1980-2002 1980-2002 1980-99
  female 1980-2002 1980,82,84-2002 1985-2002 1980-2002 1980-2002 1980-99
life expectancy at 65 1980-2002 1986-2002 1985-2002 1980-2002 1980-2002
  male 1980-2002 1986-2002 1985-2002 1980-2002 1980-2002
  female 1980-2002 1986-2002 1985-2002 1980-2002 1980-2002
total fertility rate  1980,83,89-2001 1980-2002 1980,85,87-2002 1980-81,83-2002 1980,83,85-2002 1980-2002
migration per 1000 inhabitants
crude death rate per 1000 population 1980-2002 1986-2002 1985-2002 1980,85,89-90,92,94-98
Other demand factors 
health status (share of people in bad health)
health behaviour: alcohol consumption 1981-2001
health behaviour: tobacco consumption 1980-2000 1993-2000 1996-2000 1980-2000 1991-97 1980-98
education level - attainment ISCED 0/1/2 1994-2002 1996-2002 1990-2002
education level - attainment ISCED 3/4 1994-2002 1996-2002 1990-2002
education level - attainment ISCED 5B 1994-96 1996-2002
education level - attainment ISCED 5A/6 1994-2002 1996-2002 1991-2002
Utilisation of health care services
doctor's consultation per capita 1980-2002 1993-2002 1980-81,92-2002
SUPPLY FACTORS
Supply of health care services
physicians per 1 000 inhabitants 1980-2002 1980,83,84-95,98-2002 1980,82,84-2002 1980-2002 1980-2002 1980-2002
physicians per 100 hospital beds 1985-2001 1980,82,84-95,98-2002 1980,82,84-2002 1980-2002 1980-82,84-2002 1980-2001
acute care beds per 1 000 inhabitants 1980,84-2002 1985-2002 1980,85-2002 1996 1980-2002
acute care occupancy rate % of available beds 1980,84-2002 1995-2002 1980,85-2002 1995-96 1981-2002
nursing and elderly home beds per 100 000 inhabitants 1996-2002
MRI (and CT scanners) per million inhabitants 1990-97 1994-2002 1995-96,2001-02
(MRI and) CT scanners per million inhabitants 1980-97 1980-2002 1989-90,93-2002
dialyses per 100 000 inhabitants 1994-2002 1995-2002
Bulgaria Turkey Poland
1980-2003
1980/84, 1985/89, 1990/94, 1995/99, 2000-02
1980,85,90-2003
1980-2003
Romania
1980-81,85-86,90-2003
Slovakia Slovenia
1985-2003
1980/84,1985/89,1990/94,1995/99,2000-02
1980-2001
1980,85,90-2002 1985,90-2003 1980-2003INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 19 
 
Table 4. Continued 
 
Countries
Variable
HEALTH CARE SYSTEM
Organisational structure
Health care system (public contract, public integrated, mixed) 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Gatekeeper to non-acute hospital treatment or specialist 1990-2003 1994-2003 1992-2003 1980-2003 1994-2003 1980-2003
Free choice GP or family doctor 1990-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003
Free choice of specialists 1990-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003
Free choice of hospitals 1990-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003
Free choice of dentists 1990-2003 1993-2003 1992-2003 1980-2003 1980-2003 1980-2003
Waiting lists for specialist care 1980-2003 1993-2003 1992-2003 1992-2003 1980-2003 1980-2003
waiting lists for surgeries in hospitals 1980-2003 1993-2003 1992-2003 1992-2003 1980-2003 1980-2003
Financing the health care system
Population covered by public health system % of total population 1994-2002 1980-90,93-97
Multiple or single source financing system 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
population covered by privates health insurance 1990-2003 1993-2003 1993-2003 1999-2003 1998-2003 1980-2003
Co-payment in connection with GP visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with specialists visits 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payment in connection with hospital admission 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co-payments in connection with dentist care 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Co.payments for pharmaceuticals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
Reimbursement of hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(global budget, fee-for-service, per diem, per discharge)
Reimbursement of physicians in hospitals 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, fixed salary)
Reimbursement of general practitioner 1980-2003 1994-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of specialists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Reimbursement of dentists 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003 1980-2003
(fee-for-service, salary, capitation)
Overall ceiling of hospital expenditure 1993-2003 1992-2003 1980-2003 1980-2003
FRAMEWORK CONDITIONS
Gross domestic product per capita, US$ PPP
female labour force participation (18-65?)
unemployment rate  in % of labor force 1990-2001 1990-2002 1980,82,84-2001 1990-2002 1990-2002 1982-2002
Sources:
EUROSTAT
OECD health Data 2004, Version 1
European health for all database, WHO Regional Office for Europe, Copenhagen, Denmark.
Own created variables based on literatur review
Turkey Poland Romania Slovakia Slovenia Bulgaria20 | ERIKA SCHULZ  
 
3 Statistical  overview 
3.1  Health care expenditure 
In $US PPP, the EU-15 member states have spent on average $2,400 for health care per capita 
in 2002, while the new member states have spent only $800 (Figure 2). Across the countries the 
range of health care expenditure is high. Luxembourg showed the highest amount of health care 
expenditure per capita (around $3,100), followed by Germany with $2,800, while the candidate 
countries Turkey and Romania with $450 and $275 respectively showed the lowest expenditure 
on health care per capita. Thus, the health expenditure per capita in Germany was 10 times that 
of Romania. 
Figure 2. Health care expenditure per capita in 2002 ($US PPP) 
 
Throughout the EU-15 health care expenditure per capita has increased, but the higher end of it 
has always been realised by Germany and the lower end by Portugal (Figure 3). But in the last 
four years Luxembourg has overtaken Germany. Health care expenditure increased 6.4 times in 
Portugal and 3 times in Sweden between 1980 and 2002. The bandwidth across the countries 
has expanded in the last two decades. In 1980 the health care expenditure per capita in Germany 
was $560 higher than in Portugal; in 2002 the difference was $1100. Nevertheless, in 1980 
Germany spent more than three times the amount on health care as Portugal, but in 2002 this 
figure had reduced to only 1.6 times. 
Germany also spent the highest share of national income (GDP) on health care expenditure – 
10.9% in 2002 – while Romania only spent 4.2% (Figure 4). The EU-15 spent on average 9% of 
GDP on health care in 2002, while the new member states spent 6.4%. The proportion of GDP 
spent on health care has on average increased in the last decade in the EU-15 (+0.7 percentage 
points) as well as in the new member states (+0.6 percentage points). The proportion of GDP 
spent on health care increased in all countries with the exceptions of Finland, Luxembourg, 
Poland and Lithuania. Finland experienced the greatest decline, of around 2 percentage points 
between 1992 and 2002. In the 1980s an increase in the share of GDP spent on health care could 
also be observed in the EU-15 on average, but to a more moderate degree (Figure 5). Since the 
beginning of the 1990s the development has accelerated. The growth rate in the 1990s was 1.5 
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times higher than in the 1980s. A strong dynamic can also be observed in the new member 
states at the beginning of the 1990s, but between 1994 and 2000 the proportion of GDP spent on 
health care was more or less the same, and in the last two years the share of GDP spent on 
health care has again increased.  
Figure 3. Development of health care expenditure per capita in 1980-2003 in the EU-15 ($US 
PPP) 
 
Figure 4. Health care expenditure as a percentage of GDP 
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Figure 5. Total expenditure on health as a percentage of GDP 
 
Total health care expenditure in most countries is financed by taxes or contributions to statutory 
health insurance schemes (or both). Therefore, a large proportion of health expenditure is 
publicly financed. Privately financed health care includes out-of-pocket payments (fees for 
consultations, co-payments for pharmaceuticals, dental products [prostheses], orthopaedic aid, 
self-paid pharmaceuticals, etc.) and contributions to private health insurance schemes. The share 
of publicly financed health expenditure in 2002 ranged from 100% in Romania to 37% in 
Cyprus (Figure 6). A traditionally high proportion of publicly financed health expenditure exists 
in the Nordic countries (Denmark, Finland and Sweden), but also in Luxembourg and the UK. 
The share of publicly financed health expenditure was over 80% in these countries (with the 
exception of Finland) in 2002. The share of publicly financed health expenditure has decreased 
during the last two decades in all of the EU-15 countries with the exception of Portugal. The 
latter shows an increase of around 6 percentage points between 1980 and 2002 (Figure 7). The 
new member states generally experienced a change in the political system from a Soviet to a 
market model, and thus a change in their health care infrastructures and financing. In the Soviet 
model health care was tax-financed without co-payments. In the 1990s, statutory health care 
insurance schemes were introduced and as well as co-payments. Therefore, the share of publicly 
financed health expenditure decreased. In 2002, Latvia in particular showed a marked decline in 
publicly financed health care from 88% in 1996 to 68% in 2002. 
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Figure 6. Public health expenditure as a share of total health expenditure (2002) 
 
Figure 7. Development of public finance in total health expenditure in the EU-15 
 
3.2  Demography and behaviour 
The use of health care services is influenced by the number of inhabitants, but also by the age 
structure of the population. As previously mentioned, health care expenditure for the elderly is 
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two to four times higher than that for persons aged 0-64 (see Table 1). Therefore, the proportion 
of the elderly was included in the data set. In 2001 the proportion of persons aged 65+ in the 
total population of the EU-15 was 16.3%, in the new member states it was 13.1% and in the 
three candidate countries (CC-3) it stood at 14.2%, in which the share of persons aged 85+ in 
the EU-15 was twice as much as in the new member states and the CC-3 (Whereas in general an 
increase in the proportion of the elderly could be observed in the last two decades, a steady 
growth cannot be shown in the single age groups in the EU-15 (Figure 9). The share of persons 
aged 65-74 decreased in the first years of the 1980s, followed by a phase of slow increase. The 
rising trend sped up in the beginning of the 1990s, and in the last years of the decade there was 
nearly no change at all. The share of persons aged 75-84 showed a decreasing trend at the 
beginning of the 1990s, while the share of the oldest old (85+) showed a steady increase. 
The development was different across the countries ( 
Figure 10). In the 1980s Sweden had the highest proportion of persons aged 65-74 in the total 
population, but it was replaced by Greece in the mid-1990s. Poland showed the lowest share of 
persons aged 65-74 in the 1980s, which was overtaken by Ireland at the beginning of the 1990s. 
Over the last 20 years some countries have shown a decrease (for example Austria, Sweden, 
Denmark and the Czech Republic), while others a significant increase in the proportion of 
persons aged 65-74 (for example Greece, Portugal and Spain).  
Figure 8). The highest share of persons aged 65+ was revealed to be in Italy, with 18.3% in 
2001, followed by Sweden (17.2%). Turkey had the lowest share of elderly persons with 6%. 
Whereas in general an increase in the proportion of the elderly could be observed in the last two 
decades, a steady growth cannot be shown in the single age groups in the EU-15 (Figure 9). The 
share of persons aged 65-74 decreased in the first years of the 1980s, followed by a phase of 
slow increase. The rising trend sped up in the beginning of the 1990s, and in the last years of the 
decade there was nearly no change at all. The share of persons aged 75-84 showed a decreasing 
trend at the beginning of the 1990s, while the share of the oldest old (85+) showed a steady 
increase. 
The development was different across the countries ( 
Figure 10). In the 1980s Sweden had the highest proportion of persons aged 65-74 in the total 
population, but it was replaced by Greece in the mid-1990s. Poland showed the lowest share of 
persons aged 65-74 in the 1980s, which was overtaken by Ireland at the beginning of the 1990s. 
Over the last 20 years some countries have shown a decrease (for example Austria, Sweden, 
Denmark and the Czech Republic), while others a significant increase in the proportion of 
persons aged 65-74 (for example Greece, Portugal and Spain).  INFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 25 
 
Figure 8. Proportion of the elderly in the total population (2001) 
 
Figure 9. Proportion of the elderly in the total population of the EU-15 
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Figure 10. Proportion of persons aged 65-74 in the total population 
 
All countries have shown an increase in the proportion of persons aged 75+ over the last 20 
years (Figure 11). The highest increase can be observed for Italy (4 percentage points between 
1980 and 2003), followed by Spain (3.7 percentage points), while the lowest is shown by 
Ireland and Luxembourg (1.1 percentage points each). But over the total period Sweden showed 
the highest share of persons aged 75+ and Slovakia and Poland the lowest. The increasing share 
of the elderly is not only influenced by the growing life expectancy at age 65, but also by 
changes in the fertility rate. Figure 12 presents the relation between changes in the proportion of 
persons aged 65 and changes in life expectancy at age 65. In all countries the changes in life 
expectancy and those in the proportion of the elderly show the same positive sign (with the 
exception of Austria); nevertheless, there are great differences across countries.  
Figure 11. Proportion of persons aged 75+ in the total population 
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Figure 12. Changes in life expectancy at age 65 and changes in the share of persons aged 65+ 
between 1980 and 2003 
 
It is expected that the health care expenditure per capita is positively correlated with the 
proportion of the elderly in the population. A cross-section analysis shows a positive trend in 
general, but with a great interval (Figure 13).  
Figure 13. Health care expenditure per capita and share of persons aged 65+ in 2001 
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Alongside the demographic variables the behaviour of the population has an impact on the use 
of health care services. Two behavioural factors were analysed: alcohol consumption and 
tobacco consumption. The European region has 15% of the world’s population, but nearly 33% 
of the worldwide burden of tobacco-related diseases (WHO, 2004). The annual number of 
mortalities in the region attributable to the consumption of tobacco products was recently 
estimated to be 1.2 million. About half of the mortalities affect persons in middle age. 
Therefore, a high proportion of persons who smoke in the population may lead to higher health 
care expenditures. In the EU-15, cigarette consumption per person was on average 1,610 
cigarettes per year in 2000, while in the new member states the figure was higher at 1,820 
cigarettes per person per year (Figure 14). Bulgaria showed the highest level of consumption at 
around 2,800, followed by Greece with 2,540 cigarettes. The Nordic countries Finland and 
Sweden showed the lowest consumption at around 900 cigarettes. 
Figure 14. Number of cigarettes consumed per person per year (2000) 
 
Alcohol abuse is an important public health problem. Regular drinking of more than small 
amounts cause or aggravate health problems and increases the risks of injury to the drinker and 
others (European Commission, 2003). Therefore, high levels of alcohol consumption among the 
population may have an increasing impact on health expenditure. Adults consumed 11.4 litres of 
pure alcohol on average in the EU-15 in 2002 (Figure 15). In the new member states the pure 
alcohol consumption was slightly less at 10.5 litres per capita. Luxembourg showed the highest 
level of alcohol consumption, 17.2 litres, which is one and a half times the EU average. On the 
other end of the scale, Turkey showed the lowest level of alcohol consumption at 1.5 litres. The 
high level of alcohol consumption in Luxembourg is notable. It can be traced back to heavy 
drinking/high levels of alcohol consumption on the part of visitors and tourists. Österberg & 
Karlsson (1998) reported large numbers of visitors buying alcohol in Luxembourg. They cite a 
study from Hurst et al. (1997) in which 70 to 75% of all sales of distilled spirits was estimated 
to have been purchased by visitors in Luxembourg. But drinking behaviour may also affect the 
figure for Luxembourg. The WHO reported that mortality from liver cirrhosis in Luxembourg is 
30% higher than the EU average. Luxembourg’s mortality rate from alcohol-related causes is 
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also among the highest after Slovenia and Finland, among both men and women, suggesting 
harmful drinking patterns in Luxembourg (WHO, 2005). 
Another interesting indicator for demand-driven health care expenditure may be the self-
reported health status of a population, but information is scare. The OECD health data provide 
some information, but data are not available as a long time series and not for all countries. For 
example, the collected data for 2002 are shown in Figure 16. The proportion of persons 
reporting to be in good health is highest in Luxembourg with 91% and lowest in Slovakia with 
35%. The figure for Luxembourg is astonishing in view of the high level of alcohol 
consumption mentioned above. 
Figure 15. Pure alcohol consumption in litres per capita of the population aged 15+ (2002) 
 
Figure 16. Proportion of the population in good health (2002) 
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3.3  Physicians and technical equipment 
The allocation of health care services is not costless and therefore supply factors are also drivers 
of health care expenditure. Such factors include the number of employees in the health care 
sector and the technological equipment in ambulatory and hospital care, but also the availability 
and accessibility of health care resources (number of hospitals and hospital beds, number of 
health care centres, number of medical practices and number of pharmacies). Supply and 
demand factors (or utilisation) are not independent. A high density of health care services 
induces high utilisation rates, while waiting lists for elective surgery, for example, are a limiting 
factor for utilisation. Some indicators have been included in the data set and are described 
below. 
In the EU-15, there were 3.6 practising physicians per 1,000 inhabitants in 2002, while in the 
new member states there were only 2.8 (Figure 17). The highest density was in Italy, with 6.2 
physicians per 1,000 inhabitants, followed by Greece with 4.5. The candidate countries 
Romania and Turkey had the lowest density with respectively 1.9 and 1.3 physicians per 1,000 
inhabitants in 2002. In the last two decades the density of physicians increased in all the EU-15 
countries (Figure 18). Among the EU-15, Italy had the highest density over the last two decades, 
while the UK had the lowest density in all years. Nevertheless, all the countries realised the 
same increasing trend during this period. Among the new member states and the three candidate 
countries, however, the development has been different in the last 20 years: some countries 
showed an increasing trend, while others the opposite. Latvia had the highest density in the 
1980s, but at the beginning of the 1990s there was a marked decrease. This development could 
be traced back to the changes in its political and economic situation. Lithuania replaced Latvia 
in terms of physician density in the 1990s. Turkey had the lowest density during the whole 
period, but also experienced an overall increase in density (Figure 19).  
Figure 17. Practising physicians per 1,000 inhabitants (2002) 
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Figure 18. Practising physicians per 1,000 inhabitants in the EU-15 
 
 
Figure 19. Practising physicians per 1,000 inhabitants in the new member states and the CC-3 
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Slovakia were in a favourable situation with around 7 beds per 1,000 inhabitants, while those in 
Turkey were in a less favourable situation with only around 2 beds. Over the period 1980 to 
2002 a more or less decreasing trend can be observed for all EU-15 member states, with the 
highest density in Germany and the lowest in the UK (Figure 21). In 1995 the supply of acute 
care beds in the UK increased markedly, and since 1995 Sweden has shown the lowest number 
of acute care beds per 1,000 inhabitants. A decreasing trend in the last 20 years can be observed 
in the new member states and the three candidate countries as well. The exception to this 
development has been Turkey, which has shown an increase overall, but this rise comes from a 
very low initial level (Figure 22). 
Figure 20. Acute care beds per 1,000 inhabitants in 2002 
 
Figure 21. Acute care beds per 1,000 inhabitants in the EU-15 
0
1
2
3
4
5
6
7
Slovakia
Czech Republic
Germany
Austria
Lithuania
Hungary
Belgium
Luxembourg
Latvia
Romania
NMS 10
Poland
Estonia
Slovenia
Cyprus
Greece
EU 15
France
Italy
United Kingdom
Malta
Denmark
Netherlands
Portugal
Spain
Ireland
Finland
Sweden
Turkey
0
1
2
3
4
5
6
7
8
9
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Austria Belgium Denmark Finland France Germany Greece Ireland
Italy Luxembourg Netherlands Portugal Spain Sweden United KingdomINFLUENCE OF SUPPLY AND DEMAND FACTORS ON HEALTH CARE EXPENDITURE | 33 
 
Figure 22. Acute care beds per 1,000 inhabitants in the new member states and the CC-3 
Information about the supply of technical equipment is not available for all countries or for all 
years. For example, the computed tomography (CT) scanners per million of the population in 
2002 is shown in Figure 23. Belgium had the highest number of CT scanners with around 30 per 
million inhabitants, followed by Austria. The CT facilities were lowest in Hungary, the UK and 
Poland (with around 7 or 6 units per million inhabitants respectively).  
Figure 23. CT scanners per million of the population (2002) 
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3.4  Economic situation  
The economic situation is one of the famous determinants of health care expenditure. High 
economic growth rates facilitate the expansion of health care services, the reduction of waiting 
list for elective surgeries and the purchase of new technical equipment. One indicator of the 
economic situation is the GDP per capita. In 2002 there was a wide spectrum of GDP per capita 
among the EU countries and the candidate countries (Figure 24). The GDP per capita in 
Luxembourg, at nearly $50,000 (PPP), was significantly higher than in other EU countries, 
followed at a far distance by Ireland, having $33,000 (PPP). The lowest GDP per capita was had 
seen in the three candidate countries Bulgaria ($7,200 PPP), Romania ($6,700 PPP) and Turkey 
($6,500 PPP). 
Figure 24. GDP per capita in 2002 ($US PPP) 
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EU countries. In 2002 a high positive correlation can be observed (Figure 25).  
Another indicator of the economic situation is the unemployment rate. Poland (at 20%), 
Slovakia (at 19%) and Bulgaria (at 18%) showed high unemployment rates in 2002 (Figure 26). 
But perhaps the unemployment figures are overestimated (especially among the younger age 
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Figure 25. Health care expenditure and GDP per capita (2002) 
 
Figure 26. Unemployment rate (2002) 
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were classified as public integrated systems: Denmark, Finland, Ireland, Italy, Spain, Sweden, 
the UK, Latvia and Malta. Classified as public contract systems were: Austria, Belgium, 
Germany, Luxembourg, the Netherlands, the Czech Republic, Estonia, Poland, Slovakia and 
Slovenia. All other countries were classified as mixed systems or systems in transition (Table 
5). Public integrated systems are mostly financed by taxation, but among these only a few 
countries solely derive their finance through taxation (Denmark, Ireland, Italy, Spain, Latvia and 
Malta). Nevertheless, out-of-pocket payments (co-payments and/or private insurance) also exist 
in these countries. 
In several countries co-payments for visits to a GP, a specialist or a dentist, or for a hospital stay 
or pharmaceuticals are common. The co-payment system is complex in most countries and fees 
have changed over time. There was no co-payment system in place for visiting a GP in 
Germany, Greece, Italy, the Netherlands, Spain, the UK, the Czech Republic, Hungary, 
Lithuania or Malta in 2003. In 2004, however, the situation in Germany changed, whereby 
patients now have to pay €10 per quarter for visiting a practitioner. Generally, in 2003 there 
were no co-payments for hospital stays in Denmark, Greece, Italy, the Netherlands, Portugal, 
Spain, the UK, the Czech Republic, Estonia, Hungary, Lithuania, Malta, Poland, Slovakia, 
Romania or Turkey, but charges were common for extra services (a single room, telephone, 
etc.). In all countries there were co-payments for pharmaceuticals with the exception of Malta. 
Table 5. Classification of health care systems (2003) 
 
Another indicator differentiating the health care system is the existence of a gatekeeper. It is 
expected that if a GP or family doctor acts as a gatekeeper to other health care services 
(specialists, hospitals, MTR diagnoses, etc.) the incentives for extensive health care utilisation 
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system or a global budget was in place, but in more and more countries case-based 
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statutory for all hospitals. A global budget was still being used in Ireland, Luxembourg, Spain, 
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Cyprus, the Czech Republic, Malta and Turkey in 2003. A case-based system was introduced in 
Austria, Italy, Hungary, Lithuania, Poland, Slovakia and Slovenia. 
Physicians can be reimbursed by salary, capitation or fees for services, but in nearly all 
countries some mix of these systems exists. In 2003, GPs were mainly salaried in Spain and 
Portugal (along with those GPs in health care centres in Finland), but in 1999 a mix of salary 
and capitation was introduced in Portugal. GPs were mainly remunerated by capitation in 
Ireland, Italy, Hungary and Bulgaria, and a fee-for-service remuneration was present in 
Belgium, France, Germany and Luxembourg in 2003. 
Two other indicators describing the health care system are i) the existence of waiting lists for 
elective surgery, which is an indicator of a gap between demand and health care service supply 
in this field, and ii) whether patients have a free choice of hospitals. There are waiting lists in 
several countries, and with respect to long waiting times countries generally tend to tighten 
measures to reduce the wait. In 2003 countries with waiting lists were Denmark, Finland, 
Ireland, Italy, the Netherlands, Portugal, Spain, Sweden, the UK, Cyprus, Estonia, Hungary, 
Latvia (mostly for specialists), Malta and Slovenia. A free choice of hospitals did not exist in 
Greece, Spain, Cyprus or Malta that year, and in the UK it was the family doctor who chose the 
hospital. In a number of countries a referral was needed for hospital treatments, which was the 
case in Germany, Ireland, Italy, Portugal, the Czech Republic, Estonia, Hungary, Latvia, 
Poland, Slovenia, Bulgaria and Romania.  
4  Main findings and conclusions 
The aim of WP6 of the AHEAD project is to explain how demand and supply factors influence 
aggregate health care expenditure with a specific focus on age composition. Several studies in 
the past have shown that health care expenditure is not only influenced by demand factors, but 
also by those on the supply side, particularly technological progress, political decisions and 
economic framework conditions. In contrast with other studies (and aside from the focus on 
age), WP6 emphasises variables describing health care and financing systems. The idea is that 
the inclusion of these variables affords a better explanation of health care expenditure.  
The first step in verifying this hypothesis involves collecting the required data. Thus the task of 
Part A of WP6 has been to collect data on demand, supply and utilisation of health care from 
official statistics and to create additional variables describing the health care and financing 
systems based on a literature review. In total, 63 variables have been included in a basic data set 
for 28 countries, mostly covering the period 1980-2003. As information for Cyprus and Malta 
information was found to be scarce, these countries have had to be deleted from the data set to 
be used for further analyses. Nevertheless, in the basic data set all available information is 
incorporated, including that for these two countries.  
The development of some of the variables for the countries has been shown in a brief statistical 
overview. The expected strong connection between health care expenditure and GDP can be 
seen in a cross-section analysis for 2003. The relation between health care expenditure and the 
share of elderly persons in the population was also positive, but not as strong as in the case of 
GDP. 
Based on a selection of variables from the basic data set, correlation analyses have been carried 
out by the Department of Public Health at the University of Southern Denmark (Prof. 
Christiansen, Prof. Bech and Mr. Nielsen). Their results will be presented in a separate 
forthcoming paper (Part B of WP6).   
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